Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?

Ann Transplant · 2021 · PMC8485698 · PMID 34580271

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This is highly significant as it can minimize the risk of thromboembolic events before and after transplantation in patients with ventricular assist devices, mechanical heart valves, venous thromboembolism, and coronary artery disease and history of stroke.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.